Patient-centered care for left ventricular assist device therapy: Current challenges and future directions

Current Opinion in Cardiology

Volumn 31, Issue 3, 2016, Pages 313-320

  Breathett, Khadijah ^a   Allen, Larry A ^a   Ambardekar, Amrut V ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

Decision making; Heart failure; Left ventricular assist device; Mechanical circulatory support

Indexed keywords

AFRICAN AMERICAN; ASSISTED CIRCULATION; AUTOREGULATION; BODY SIZE; CARDIOVASCULAR MORTALITY; CAREGIVER; CEREBROVASCULAR ACCIDENT; COMORBIDITY; CONTINUOUS FLOW LEFT VENTRICULAR ASSIST DEVICE; DECISION SUPPORT SYSTEM; DEVICE INFECTION; DEVICE MALFUNCTION; HEALTH INSURANCE; HEART FAILURE; HUMAN; HYPERTENSION; KNOWLEDGE BASE; MEDICAL DEVICE COMPLICATION; MULTIPLE ORGAN FAILURE; PATIENT CARE; PATIENT SELECTION; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SOCIAL SUPPORT; SURVIVAL; HEART ASSIST DEVICE; RISK ASSESSMENT; TRENDS;

HEART-ASSIST DEVICES; HUMANS; PATIENT-CENTERED CARE; RISK ASSESSMENT;

EID: 84958818425     PISSN: 02684705     EISSN: 15317080     Source Type: Journal    
DOI: 10.1097/HCO.0000000000000279     Document Type: Review

References (44)

1. Institution of Medicine (US) Committee on Quality of Health Care in America. Crossing the quality chasm: a new health system for the 21st century. Washington, DC: National Academies Press (US); 2001.
2. Miller LW, Pagani FD, Russell SD, et al. Use of a continuous-flow device in patients awaiting heart transplantation. N Engl J Med 2007; 357:885-896.
3. Aaronson KD, Slaughter MS, Miller LW, et al. Use of an intrapericardial, continuous-flow, centrifugal pump in patients awaiting heart transplantation. Circulation 2012; 125:3191-3200.
4. Slaughter MS, Rogers JG, Milano CA, et al. Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med 2009; 361:2241-2251.
5. Stewart GC, Stevenson LW, Miller LW. Keeping left ventricular assist device acceleration on track. Circulation 2011; 123:1559-1568.
6. Xie A, Phan K, Yan TD. Durability of continuous-flow left ventricular assist devices: a systematic review. Ann Cardiothorac Surg 2014; 3:547-556.
7. McIlvennan CK, Magid KH, Ambardekar AV, et al. Clinical outcomes after continuous-flow left ventricular assist device: a systematic review. Circ Heart Fail 2014; 7:1003-1013.
8. Lampropulos JF, Kim N, Wang Y, et al. Trends in left ventricular assist device use and outcomes among Medicare beneficiaries, 2004-2011. Open Heart 2014; 1:e000109.
9. Kirklin JK, Naftel DC, Pagani FD, et al. Sixth INTERMACS annual report: a 10,000-patient database. J Heart Lung Transplant 2014; 33:555-564.
10. Kirklin JK, Naftel DC, Pagani FD, et al. Seventh INTERMACS annual report: 15000 patients and counting. J Heart Lung Transplant 2015; 34:1495-1504.
11. Lietz K, Long JW, Kfoury AG, et al. Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection. Circulation 2007; 116:497-505.
12. Cowger J, Sundareswaran K, Rogers JG, et al. Predicting survival in patients receiving continuous flow left ventricular assist devices: the HeartMate II risk score. J Am Coll Cardiol 2013; 61:313-321.
13. Yancy CW, Jessup M, Bozkurt B, et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2013; 62:e147-e239.
14. Feldman D, Pamboukian SV, Teuteberg JJ, et al. The 2013 International Society for Heart and Lung Transplantation Guidelines for mechanical circulatory support: executive summary. J Heart Lung Transplant 2013; 32:157-187.
15. Rogers JG, Butler J, Lansman SL, et al. Chronic mechanical circulatory support for inotrope-dependent heart failure patients who are not transplant candidates: results of the INTrEPID Trial. J Am Coll Cardiol 2007; 50:741-747.
16. Hershberger RE, Nauman D, Walker TL, et al. Care processes and clinical outcomes of continuous outpatient support with inotropes (COSI) in patients with refractory endstage heart failure. J Card Fail 2003; 9:180-187.
17. Rose EA, Gelijns AC, Moskowitz AJ, et al. Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med 2001; 345:1435-1443.
18. Boyle AJ, Ascheim DD, Russo MJ, et al. Clinical outcomes for continuous-flow left ventricular assist device patients stratified by preoperative INTERMACS classification. J Heart Lung Transplant 2011; 30:402-407.
19. Estep JD, Starling RC, Horstmanshof DA, et al. Risk assessment and comparative effectiveness of left ventricular assist device and medical management in ambulatory heart failure patients: results from the ROADMAP Study. J Am Coll Cardiol 2015; 66:1747-1761.
20. Kato TS, Chokshi A, Singh P, et al. Effects of continuous-flow versus pulsatileflow left ventricular assist devices on myocardial unloading and remodeling. Circ Heart Fail 2011; 4:546-553.
21. Tarzia V, Buratto E, Bortolussi G, et al. Hemorrhage and thrombosis with different LVAD technologies: a matter of flow? Ann Cardiothorac Surg 2014; 3:582-584.
22. Cornwell WK, Tarumi T, Aengevaeren VL, et al. Effect of pulsatile and nonpulsatile flow on cerebral perfusion in patients with left ventricular assist devices. J Heart Lung Transplant 2014; 33:1295-1303.
23. Ambardekar AV, Hunter KS, Babu AN, et al. Changes in Aortic Wall Structure, Composition, and Stiffness With Continuous-Flow Left Ventricular Assist Devices: A Pilot Study. Circ Heart Fail 2015; 8:944-952.
24. Cornwell WK, Tarumi T, Stickford A, et al. Restoration of pulsatile flow reduces sympathetic nerve activity among individuals with continuous-flow left ventricular assist devices. Circulation 2015; 132:2316-2322.
25. MOMENTUM 3 IDE Clinical Study Protocol (HM3TM). https://clinicaltrials.gov/ct2/show/NCT02224755. [Accessed 30 November 2015]
26. Dunlay SM, Park SJ, Joyce LD, et al. Frailty and outcomes after implantation of left ventricular assist device as destination therapy. J Heart Lung Transplant 2014; 33:359-365.
27. Galvao M, Saeed O, Immekus J, et al. An international survey to assess referral thresholds for destination therapy in noninotrope-dependent patients: results of the CONSENSUS-DT study. J Card Fail 2014; 20:492-497.
28. Allen LA, Stevenson LW, Grady KL, et al. Decision making in advanced heart failure: a scientific statement from the American Heart Association. Circulation 2012; 125:1928-1952.
29. Kalogeropoulos AP, Georgiopoulou VV, Giamouzis G, et al. Utility of the Seattle Heart Failure Model in patients with advanced heart failure. J Am Coll Cardiol 2009; 53:334-342.
30. Mozaffarian D, Benjamin EJ, Go AS, et al. Heart disease and stroke statistics: 2015 update: a report from the American Heart Association. Circulation 2014; 131:e29-e322.
31. Aggarwal A, Gupta A, Pappas PS, et al. Racial differences in patients with left ventricular assist devices. ASAIO J 2012; 58:499-502.
32. Joyce DL, Conte JV, Russell SD, et al. Disparities in access to left ventricular assist device therapy. J Surg Res 2009; 152:111-117.
33. Nelson A. Unequal treatment: confronting racial and ethnic disparities in healthcare. J Natl Med Assoc 2002; 94:666-668.
34. Pinney SP. Understanding and eliminating racial disparities in transplantation: still a ways to go. J Am Coll Cardiol 2013; 62:2316-2317.
35. Aaronson KD, Schwartz JS, Goin JE, et al. Sex differences in patient acceptance of cardiac transplant candidacy. Circulation 1995; 91:2753-2761.
36. McIlvennan CK, Jones J, Allen LA, et al. Decision-making for destination therapy left ventricular assist devices: implications for caregivers. Circ Cardiovasc Qual Outcomes 2015; 8:172-178.
37. McIlvennan CK, Allen LA, Nowels C, et al. Decision making for destination therapy left ventricular assist devices: 'there was no choice' versus 'I thought about it an awful lot'. Circ Cardiovasc Qual Outcomes 2014; 7:374-380.
38. Kirkpatrick JN, Kellom K, Hull SC, et al. Caregivers and left ventricular assist devices as a destination, not a journey. J Card Fail 2015; 21:806-815.
39. Baker K, Flattery M, Salyer J, et al. Caregiving for patients requiring left ventricular assistance device support. Heart Lung J Crit Care 2010; 39:196-200.
40. Bekelman DB, Nowels CT, Retrum JH, et al. Giving voice to patients' and family caregivers' needs in chronic heart failure: implications for palliative care programs. J Palliat Med 2011; 14:1317-1324.
41. Iacovetto MC, Matlock DD, McIlvennan CK, et al. Educational resources for patients considering a left ventricular assist device: a cross-sectional review of internet, print, and multimedia materials. Circ Cardiovasc Qual Outcomes 2014; 7:905-911.
42. Thompson J, Matlock D, McIlvennan C, et al. Development of a decision aid for patients with advanced heart failure considering a destination therapy left ventricular assist device. JACC Heart Fail 2015; 3:965-976.
43. A decision aid for left ventricular assist device (LVAD) for destination therapy: A device for patients with advanced heart failure [online]. https://decisionaid. ohri.ca/AZsumm.php?ID=1799. [Accessed 30 November 2015]
44. PCORI-1310-06998 trial of a decision support intervention for patients and caregivers offered destination therapy heart assist device (DECIDE-LVAD). https://clinicaltrials.gov/ct2/show/NCT02344576. [Accessed 30 November 2015]